Hhlr Advisors, Ltd. Portfolio Holdings

Hhlr Advisors, Ltd.

  • $2.61 Billion
  • Q4 2024

Hhlr Advisors, Ltd. has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $2.61 Billion distributed in 45 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bei Gene, Ltd. with a value of $703M, Alibaba Group Holding LTD with a value of $414M, Pinduoduo Inc. with a value of $265M, Net Ease, Inc. with a value of $231M, and Ke Holdings Inc. with a value of $208M.

Examining the 13F form we can see an decrease of $1.75B in the current position value, from $4.36B to 2.61B.

Hhlr Advisors, Ltd. is based out at Grand Cayman, E9

Below you can find more details about Hhlr Advisors, Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $2.61 Billion
Consumer Cyclical: $1.01 Billion
Healthcare: $984 Million
Communication Services: $239 Million
Real Estate: $208 Million
Financial Services: $93.8 Million
Technology: $71.2 Million
Industrials: $11.1 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$23.5B
$703 Million 26.88% of portfolio
3,804,406
Q4 2024 Reduced 26.51%
$381B
$414 Million 15.85% of portfolio
4,887,300
Q4 2024 Reduced 44.64%
$166B
$265 Million 10.13% of portfolio
2,730,275
Q4 2024 Reduced 42.72%
$67.8B
$231 Million 8.84% of portfolio
2,588,943
Q3 2024 Added 86.82%
$26.2B
$208 Million 7.97% of portfolio
11,261,276
Q4 2024 Added 3.61%
$9.36B
$200 Million 7.67% of portfolio
14,880,002
Q4 2024 Reduced 5.35%
$6.65B
$195 Million 7.45% of portfolio
5,984,550
Q4 2024 Reduced 9.82%
$17.8B
$89.5 Million 3.42% of portfolio
1,118,303
Q4 2024 Added 6.39%
$43B
$62.7 Million 2.4% of portfolio
913,842
Q4 2024 Reduced 48.5%
$66.2B
$58.6 Million 2.24% of portfolio
1,690,000
Q4 2024 Added 5.63%
$771M
$51.2 Million 1.96% of portfolio
4,975,183
Q4 2021 New
$689M
$43.2 Million 1.65% of portfolio
6,657,030
Q2 2023 Reduced 13.58%
$5.46B
$28.1 Million 1.07% of portfolio
1,023,950
Q3 2024 Reduced 26.37%
$714M
$8.73 Million 0.33% of portfolio
2,098,553
Q4 2024 New
$16.8B
$8.52 Million 0.33% of portfolio
435,927
Q4 2024 Reduced 85.48%
$1.03T
$8.41 Million 0.32% of portfolio
42,588
Q4 2024 Added 119.58%
$80.6M
$5.08 Million 0.19% of portfolio
5,980,568
Q4 2024 Reduced 13.44%
$132M
$4.48 Million 0.17% of portfolio
4,974,041
Q4 2022 Reduced 32.97%
$2.29B
$2.8 Million 0.11% of portfolio
1,564,400
Q1 2024 Reduced 2.21%
$300M
$2.84 Million 0.11% of portfolio
3,949,700
Q2 2023 Reduced 1.44%
$153B
$3 Million 0.11% of portfolio
13,079
Q4 2024 Added 43.66%
$91.7B
$2.12 Million 0.08% of portfolio
4,477
Q4 2024 Added 198.07%
$46.2B
$2.19 Million 0.08% of portfolio
3,650
Q4 2024 New
$218B
$1.72 Million 0.07% of portfolio
10,328
Q4 2024 Added 80.78%
$17.8M
$1.84 Million 0.07% of portfolio
847,510
Q1 2023 Reduced 2.65%
$346M
$1.68 Million 0.06% of portfolio
918,892
Q3 2023 New
$3.49B
$1.26 Million 0.05% of portfolio
30,000
Q3 2024 New
$497M
$847,000 0.03% of portfolio
700,000
Q4 2024 Added 16.67%
$82.2B
$863,000 0.03% of portfolio
2,338
Q4 2024 Added 210.49%
$47M
$593,000 0.02% of portfolio
382,606
Q2 2023 Reduced 27.9%
$1.61B
$413,000 0.02% of portfolio
53,590
Q4 2024 New
Arrivent Biopharma Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 14.14%
Wns Hldgs LTD
-
$0 0.0% of portfolio
-
Q4 2024 New
Yatsen Hldg LTD
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 1.46%
Bright Scholar Ed Hldgs LTD
-
$0 0.0% of portfolio
-
Q3 2023 Reduced 0.49%
Uxin LTD
-
$0 0.0% of portfolio
-
Q1 2024 New
China Jo Jo Drugstores Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Contineum Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Sagimet Biosciences Inc
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 50.0%
Ge Vernova Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 1.03%
Kiniksa Pharmaceuticals Intl
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 49.67%
Metagenomi Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Lakeshore Biopharma CO LTD
-
$0 0.0% of portfolio
-
Q4 2024 New
Aligos Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 45
  • Current Value $2.61 Billion
  • Prior Value $4.36 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 5 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 10 stocks
Track This Portfolio

Track Hhlr Advisors, Ltd. Portfolio

Follow Hhlr Advisors, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Hhlr Advisors, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email